SBIR/STTR Research Award

Cell Culture Device for Hematopoietic Progenitor Cells

Award identifier 38b5167869aa2563253b02d9d408d092ae2aad1ba03201207a5ebb89a1c6a6c9Awarding agency Department of Health and Human Services

Award amount

$80,998

Program and phase

SBIR · Phase I

Award year

1994

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
CELLEX BIOSCIENCES, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

This research will examine growth of normal human marrow in a compact cell culture"OXYCELL" bioreactor. This bioreactor is suited for experimental manipulation due to its small cellvolume and in-house manufacture. This research will examine the benefit of providing an adherentsubstrate in the bioreactor for stromal cell attachment and growth. Two distinct substrate choices,polysulfone ultrafiltration membrane and "OPTICELL" ceramic matrix, will be tested and compared.Hematopoietic lineages culture will be quantified to assess performance differences. The second partdeals with the seeking of CD34+ progenitor cells into a bioreactor in which an established stromal cellmicroenvironment is compartmentalized within a 0.2 uM microfiltration membrane. The progenitor cellswill share cell space medium with the adherent cells but will not be in direct cell-cell contact. Growthwill be compared to cells seeded directly into the microenvironment space and into a bioreactor withoutan established microenvironment. Exogenous growth factors will be tested for impact on the growthof progenitor cells seeded into the bioreactors. Cultured cells will be phenotyped for lineage commitmentand differentiative stage and assayed for uncommitted and committed progenitors. This work is todevelop a bioreactor suited for bone marrow culture applications. The bioreactor is to be incorporatedinto a cultureware to be supported by an automated cell culture instrument (currently underdevelopment) designed specifically for clinical use in immunotherapy.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.